Figure 3From: The metabolic cost of lowering blood pressure with hydrochlorothiazide(a) Changes in hepatic triglyceride content (hTG) after treatment with Valsartan and HCTZ ( p = 0.0098). (b) Changes in insulin sensitivity (SI) after treatment with HCTZ and Valsartan (p = -0.0345).Back to article page